Comprehensive Strategies for Metabolic Syndrome: How Nutrition, Dietary Polyphenols, Physical Activity, and Lifestyle Modifications Address Diabesity, Cardiovascular Diseases, and Neurodegenerative Conditions
Overview
Authors
Affiliations
Several hallmarks of metabolic syndrome, such as dysregulation in the glucose and lipid metabolism, endothelial dysfunction, insulin resistance, low-to-medium systemic inflammation, and intestinal microbiota dysbiosis, represent a pathological bridge between metabolic syndrome and diabesity, cardiovascular, and neurodegenerative disorders. This review aims to highlight some therapeutic strategies against metabolic syndrome involving integrative approaches to improve lifestyle and daily diet. The beneficial effects of foods containing antioxidant polyphenols, intestinal microbiota control, and physical activity were also considered. We comprehensively examined a large body of published articles involving basic, animal, and human studie, as well as recent guidelines. As a result, dietary polyphenols from natural plant-based antioxidants and adherence to the Mediterranean diet, along with physical exercise, are promising complementary therapies to delay or prevent the onset of metabolic syndrome and counteract diabesity and cardiovascular diseases, as well as to protect against neurodegenerative disorders and cognitive decline. Modulation of the intestinal microbiota reduces the risks associated with MS, improves diabetes and cardiovascular diseases (CVD), and exerts neuroprotective action. Despite several studies, the estimation of dietary polyphenol intake is inconclusive and requires further evidence. Lifestyle interventions involving physical activity and reduced calorie intake can improve metabolic outcomes.
Phytochemical Composition of (L.) Lam and Its Impact on the Metabolic Syndrome: A Review.
Alla C, Ali A, Mehiou A, Salhi Y, Bouanani N, Legssyer A Adv Pharmacol Pharm Sci. 2025; 2025:8276090.
PMID: 40035065 PMC: 11873318. DOI: 10.1155/adpp/8276090.
Jalouli M, Rahman M, Biswas P, Rahman H, Harrath A, Lee I Front Pharmacol. 2025; 16:1492517.
PMID: 39981183 PMC: 11840759. DOI: 10.3389/fphar.2025.1492517.
Liu S, Li H, Xi S, Zhang Y, Sun T Int J Nanomedicine. 2025; 20:1443-1490.
PMID: 39925682 PMC: 11806685. DOI: 10.2147/IJN.S457393.
The Neurometabolic Function of the Dopamine-Aminotransferase System.
Apryatin S Metabolites. 2025; 15(1).
PMID: 39852364 PMC: 11767981. DOI: 10.3390/metabo15010021.
Effect of Diet on HDL in Obesity.
Bacchetti T, Morresi C, Simonetti O, Ferretti G Molecules. 2025; 29(24.
PMID: 39770044 PMC: 11677490. DOI: 10.3390/molecules29245955.